Literature DB >> 18668384

Methyl-CpG binding domain 1 gene polymorphisms and lung cancer risk in a Chinese population.

Hongliang Liu1, Guangfu Jin, Haifeng Wang, Wenting Wu, Yanhong Liu, Ji Qian, Weiwei Fan, Hongxia Ma, Ruifen Miao, Zhibin Hu, Weiwei Sun, Yi Wang, Li Jin, Qingyi Wei, Hongbing Shen, Wei Huang, Daru Lu.   

Abstract

Polymorphisms of the methyl-CpG binding domain 1 (MBD1) gene may influence MBD1 activity on gene expression profiles, thereby modulating individual susceptibility to lung cancer. To test this hypothesis, we investigated the associations of four MBD1 polymorphisms and lung cancer risk in a Chinese population. Single locus analysis revealed significant associations between two polymorphisms (rs125555 and rs140689) and lung cancer risk (p=0.011 and p=0.005, respectively). Since the two polymorphisms were in linkage disequilibrium, further haplotype analyses were performed and revealed a significant association with lung cancer (global test p-value=0.0041). Our results suggested that MBD1 polymorphisms might be involved in the development of lung cancer. Validation of these findings in larger studies of other populations is needed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18668384     DOI: 10.1080/13547500802168031

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  3 in total

1.  The Roles of the Methyl-CpG Binding Proteins in Cancer.

Authors:  Lee Parry; Alan R Clarke
Journal:  Genes Cancer       Date:  2011-06

Review 2.  An epigenetic regulator: methyl-CpG-binding domain protein 1 (MBD1).

Authors:  Lu Li; Bi-Feng Chen; Wai-Yee Chan
Journal:  Int J Mol Sci       Date:  2015-03-05       Impact factor: 5.923

3.  Screening of Tumor Suppressor Genes in Metastatic Colorectal Cancer.

Authors:  Lu Qi; Yanqing Ding
Journal:  Biomed Res Int       Date:  2017-04-04       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.